Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities
Net loss	$ (1,649,703)	$ (5,479,137)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	70,124	61,434
Change in fair value of warrant liability	(48,096)	(707,284)
Changes in operating assets and liabilities:
Advances on research and development contract services	(321,431)	170,205
Prepaid insurance and prepaid expenses	171,229	171,482
Accounts payable and accrued expenses	(51,390)	706,881
Research and development contract liabilities	44,980	93,753
Accrued legal settlement	(414,989)
Net cash used in operating activities	(2,199,276)	(4,982,666)
Cash flows from financing activities
Proceeds from sale of common stock in public offering, net of offering costs	1,504,339	4,452,163
Exercise of pre-funded warrants	436
Net cash provided by financing activities	1,504,775	4,452,163
Net decrease in cash	(694,501)	(530,503)
Cash, beginning of period	3,026,569	7,538,312
Cash, end of period	2,332,068	7,007,809
Supplemental information
Income taxes paid
Noncash investing and financing activities
Options issued to settle accrued bonus	$ 77,400